Progyny, Inc. 8-K

What Happened

• Progyny, Inc. announced its financial results for the fiscal quarter ended March 31, 2026 via a press release dated May 7, 2026. The company furnished that press release as Exhibit 99.1 to its Form 8-K and provided a supplemental earnings presentation as Exhibit 99.2.
• The supplemental earnings presentation is also being made available on Progyny’s investor relations site (investors.progyny.com). The Form 8-K disclosure was filed under Item 7.01 (Regulation FD Disclosure) and the report was signed by CEO Peter Anevski.

Key Details

• Filing date: May 7, 2026.
• Quarter covered: Fiscal quarter ended March 31, 2026.
• Exhibits furnished: Exhibit 99.1 = press release; Exhibit 99.2 = Q1 2026 supplemental earnings presentation.
• Disclosure type: Item 7.01 (Regulation FD Disclosure); Form 8-K signed by CEO Peter Anevski.

Why It Matters

• This filing is the company’s formal public release of its quarterly earnings and related investor materials, which investors use to assess recent performance and trends.
• The supplemental presentation and press release are the primary sources for revenue, growth metrics, profitability, and any commentary management provides—investors should review those exhibits (and the investor relations site) for the detailed numbers and context.